Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019, report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office)
Type
Label
Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019, report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office)
Language
eng
Bibliography note
Includes bibliographical references
resource.governmentPublication
federal national government publication
Index
no index present
Literary Form
non fiction
Main title
Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019
Nature of contents
bibliographydictionaries
Oclc number
1107669191
Series statement
Report / 116th Congress, 1st session, House of Representatives, 116-46
Sub title
report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office)
Subject
- PPL e-gov docs collection
- Generic drugs + Standards -- United States
- Médicaments -- États-Unis -- Coût-efficacité
- Legislative materials
- Médicaments génériques + Prix
- Generic drugs + Prices
- Pharmaceutical industry -- United States -- Quality control
- Médicaments génériques + Normes -- États-Unis
- Drugs -- United States -- Cost effectiveness
- Médicaments génériques + Efficacité -- États-Unis
- Documents législatifs
- legislative records
- Industrie pharmaceutique -- États-Unis -- Qualité -- Contrôle
- Generic drugs + Effectiveness -- United States
Content
Is Part Of
Mapped to
Incoming Resources
- Has instance1
Outgoing Resources
- Creator1
- Genre3
- Subject14
- PPL e-gov docs collection
- Generic drugs + Standards -- United States
- Médicaments -- États-Unis -- Coût-efficacité
- Legislative materials
- Médicaments génériques + Prix
- Generic drugs + Prices
- Pharmaceutical industry -- United States -- Quality control
- Médicaments génériques + Normes -- États-Unis
- Drugs -- United States -- Cost effectiveness
- Médicaments génériques + Efficacité -- États-Unis
- Documents législatifs
- legislative records
- Industrie pharmaceutique -- États-Unis -- Qualité -- Contrôle
- Generic drugs + Effectiveness -- United States
- Content1
- Author1
- Is Part Of1
- Other version1
- Mapped to1